Analysis of the impact of ZEB1 expression on pathway enrichment and immune cell abundance in prostate cancer (2022)
- Autores:
- Autores USP: REIS, RODOLFO BORGES DOS - FMRP ; SQUIRE, JEREMY ANDREW - FMRP ; DUTRA, WILLIAM LAUTERT - FMRP ; SILVA, FRANCISCO CESAR DE SOUSA E - FMRP
- Unidade: FMRP
- DOI: 10.1158/1538-7445.AM2022-6098
- Assuntos: IMUNOLOGIA CELULAR; NEOPLASIAS; PRÓSTATA
- Idioma: Inglês
- Imprenta:
- Local: Philadelphia
- Data de publicação: 2022
- Fonte:
- Título: Cancer Research
- ISSN: 1538-7445
- Volume/Número/Paginação/Ano: v. 82, n. 12, suppl., res. 6098, 2022
- Nome do evento: AACR Annual Meeting
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
CHAVES, Luiz Paulo et al. Analysis of the impact of ZEB1 expression on pathway enrichment and immune cell abundance in prostate cancer. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.AM2022-6098. Acesso em: 20 out. 2024. , 2022 -
APA
Chaves, L. P., Caliari, A. L., Lautert-Dutra, W., Silva, F. C. de S. e, Melo, C. M., Saggioro, F. P., et al. (2022). Analysis of the impact of ZEB1 expression on pathway enrichment and immune cell abundance in prostate cancer. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.AM2022-6098 -
NLM
Chaves LP, Caliari AL, Lautert-Dutra W, Silva FC de S e, Melo CM, Saggioro FP, Reis RB dos, Squire JA. Analysis of the impact of ZEB1 expression on pathway enrichment and immune cell abundance in prostate cancer [Internet]. Cancer Research. 2022 ; 82( 12):[citado 2024 out. 20 ] Available from: https://doi.org/10.1158/1538-7445.AM2022-6098 -
Vancouver
Chaves LP, Caliari AL, Lautert-Dutra W, Silva FC de S e, Melo CM, Saggioro FP, Reis RB dos, Squire JA. Analysis of the impact of ZEB1 expression on pathway enrichment and immune cell abundance in prostate cancer [Internet]. Cancer Research. 2022 ; 82( 12):[citado 2024 out. 20 ] Available from: https://doi.org/10.1158/1538-7445.AM2022-6098 - Differential gene expression related to TMPRSS2-ERG fusion, CDK12, RB1, TP53, AR and ZEB1 based on transcriptomic analysis of the TCGA PRAD cohort
- Impact of CDK12 loss on immune response in TCGA prostate tumors
- Interactions between PTEN, TP53, RB1 and TMPRSS2-ERG genes in prostate cancer progression
- TCGA analysis identifies distinct genomic features of oncogenic progression and outcome associated with hemizygous PTEN loss tumors
- Risk stratification of prostate cancer through quantitative assessment of PTEN loss (qPTEN)
- Quantitative measurement of PTEN loss improves risk assessment in prostate cancer
- Trannscriptomics and immune response in human cancer
- Analysis of the relationships between ZEB1, PTEN loss, TMPRSS2-ERG fusion and immune response biomarkers in Prostate Cancer
- The role of somatic mutations on the immune response of the tumor microenvironment in prostate cancer
- Emerging role of PTEN loss in evasion of the immune response to tumours
Informações sobre o DOI: 10.1158/1538-7445.AM2022-6098 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | 003164364.pdf |
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
